Precigen, Inc. - Common Stock (PGEN)
1.4900
0.00 (0.00%)
Precigen Inc is a biotechnology company focused on developing innovative gene and cell therapies aimed at addressing a range of diseases, including cancer and genetic disorders
The company leverages its proprietary technologies to create advanced therapeutic solutions that aim to enhance the body's immune response and provide targeted treatment options. By utilizing its expertise in genetic engineering and immunology, Precigen works to bring transformative health solutions to patients while advancing the field of precision medicine.
Previous Close | 1.490 |
---|---|
Open | - |
Bid | 1.460 |
Ask | 1.540 |
Day's Range | N/A - N/A |
52 Week Range | 0.6513 - 1.930 |
Volume | 33 |
Market Cap | 376.11M |
PE Ratio (TTM) | -3.311 |
EPS (TTM) | -0.5 |
Dividend & Yield | N/A (N/A) |
1 Month Average Volume | 1,748,662 |
News & Press Releases
![](https://cdn.benzinga.com/files/images/story/2025/01/23/Palantir--Salesforce--Okta--Meta--And-Te.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · January 23, 2025
![](https://schaeffers-cdn.s3.amazonaws.com/images/default-source/schaeffers-cdn-images/2025/january/mmc/mmc-jan2.png?sfvrsn=c035a306_2)
Stocks are struggling for direction in the first trading session of the year.
Via Talk Markets · January 2, 2025
![](https://cdn.benzinga.com/files/images/story/2024/12/30/FDA-And-CDC-Involvement.jpeg?width=1200&height=800&fit=crop)
Precigen submits BLA for PRGN-2012 gene therapy targeting RRP, a rare and life-threatening condition with no cure.
Via Benzinga · December 30, 2024
![](https://cdn.benzinga.com/files/images/story/2024/08/15/Le-2-azioni-finanziarie-da-scaricare-ad-.png?width=1200&height=800&fit=crop)
Via Benzinga · August 15, 2024
![](https://cdn.benzinga.com/files/images/story/2024/08/15/Movers.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · August 15, 2024
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
PGEN stock results show that Precigen missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.
Via InvestorPlace · August 14, 2024
![](https://cdn.benzinga.com/files/images/story/2024/08/14/Penny-stock-gli-insider-muovono-il-merca.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · August 14, 2024
![](https://cdn.benzinga.com/files/images/story/2024/08/08/movers-image.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · August 8, 2024
![](https://cdn.benzinga.com/files/images/story/2024/06/03/Movers_0.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · June 3, 2024
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
PGEN stock results show that Precigen missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.
Via InvestorPlace · May 14, 2024
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
PGEN stock results show that Precigen missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023.
Via InvestorPlace · March 19, 2024
![](https://cdn.benzinga.com/files/images/story/2024/03/21/factset_research_-logo.jpg?width=1200&height=800&fit=crop)
Shares of FactSet Research Systems Inc. (NYSEFDS) fell sharply during Thursday’s session after the company reported worse-than-expected second-quarter revenue and issued FY24 guidance.
Via Benzinga · March 21, 2024
![](https://cdn.benzinga.com/files/images/story/2023/earnings_image.jpeg?width=1200&height=800&fit=crop)
Companies Reporting Before The Bell • Tencent Music Enter Gr (NYSETME) is projected to report quarterly earnings at $0.14 per share on revenue of $931.97 million.
Via Benzinga · March 19, 2024
![](https://cdn.benzinga.com/files/images/story/2024/02/12/monday.com_-_logo.jpg?width=1200&height=800&fit=crop)
U.S. stock futures were mixed this morning, with the Dow futures trading lower by around 45 points on Monday. Shares of monday.com Ltd. (NASDAQMNDY) fell sharply in today’s pre-market trading after the company reported fourth-quarter financial results.
Via Benzinga · February 12, 2024
![](https://cdn.benzinga.com/files/images/story/2024/02/12/image26.jpeg?width=1200&height=800&fit=crop)
Shares of Amtech Systems, Inc. (NASDAQASYS) rose sharply in today’s pre-market trading after the company reported upbeat results for its first quarter on Friday.
Via Benzinga · February 12, 2024
![](https://investorplace.com/wp-content/uploads/2023/12/jackpot1600.jpg)
These stocks to buy have the potential to take your portfolio to the next level thanks to the cutting-edge technology they represent.
Via InvestorPlace · December 4, 2023
![](https://cdn.benzinga.com/files/images/story/2024/01/02/image21_0.jpeg?width=1200&height=800&fit=crop)
Shares of Longboard Pharmaceuticals, Inc.
Via Benzinga · January 2, 2024
![](https://cdn.benzinga.com/files/images/story/2023/09/26/image46.jpg?width=1200&height=800&fit=crop)
Gainers Soleno Therapeutics, Inc. (NASDAQSLNO) shares jumped 318.5% to $18.54 after the company released top-line results from randomized withdrawal period of study C602 of DCCR for Prader-Willi Syndrome.
Via Benzinga · September 26, 2023
![](https://cdn.benzinga.com/files/images/story/2023/11/10/image27.jpeg?width=1200&height=800&fit=crop)
Shares of Wynn Resorts, Limited (NASDAQWYNN) fell sharply on Friday after the company reported third-quarter financial results.
Via Benzinga · November 10, 2023
![](https://cdn.benzinga.com/files/images/story/2023/09/26/fisker_-_logo.jpg?width=1200&height=800&fit=crop)
U.S. stocks traded lower, with the Dow Jones falling around 200 points on Tuesday. Here are some big stocks recording gains in today’s session.
Via Benzinga · September 26, 2023
![](https://cdn.benzinga.com/files/images/story/2023/08/25/nordstrom_-_logo.jpg?width=1200&height=800&fit=crop)
Gainers Alset Capital Acquisition Corp. (NASDAQACAX) shares climbed 66.2% to $12.93.
Via Benzinga · August 25, 2023